Posted inBiologic Drugs BioTech Medicines
A Closer Look at New FDA Guidance Removing Barriers to Biosimilar Development
The FDA has issued draft guidance that stakeholders say could significantly accelerate the entry of biosimilars into the US market, potentially unlocking substantial cost savings for the health care system.1…









